news
Age-Based Genetic Testing Misses 72% of Inherited Cancer Risks
A new study reveals that current age-based criteria for genetic testing overlook 72% of cancer patients with inherited pathogenic variants. This means many miss out on crucial information for treatment, prevention, and family risk assessment. It's a wake-up call to broaden screening beyond just age.
A new study reveals that current age-based criteria for genetic testing overlook 72% of cancer patients with inherited pathogenic variants. This means many miss out on crucial information for treatment, prevention, and family risk assessment. It's a wake-up call to broaden screening beyond just age.
The architecture take
The old rules for who gets genetic testing are clearly outdated, and this study proves it. We're talking about inherited cancer risks, which means DNA that's been passed down, not just a lifestyle choice. Skipping testing for 72% of people carrying these variants just because they're 'too young' or don't meet an arbitrary age threshold is a huge gap in prevention. It impacts not just the person diagnosed, but their entire family tree who could also be carrying the same mutation. I keep thinking about the downstream effects here: missed early interventions, less precise treatments, and families living in the dark. It’s a slow, quiet kind of chaos for the nervous system. The takeaway for me? If you have family history, push past the age criteria and ask for the genetic screening anyway. Your body holds the information, and you deserve to know it.